Clinical TrialsSearch results
Number of results: 339
Other
- Standardization of neck dissection procedures for hypopharyngeal and supraglottic carcinomas
- hypopharyngeal carcinoma, supraglottic carcinoma
- The Japan Neck Dissection Study Group (JNDSG)
- 2009-05-28
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with Hypertension
- Atrial Fibrillation with Hypertension
- The J-RHYTHM II Investigators
- 2006-07-10
Other
- A comparing study between open and close of retroperitonium on lymphedema of the lower extremities after surgeries of both uterine cervical and endometrial cancer (a randomized study by multi-institutes)
- uterine cervical and endometrial cancer
- The development reserarch cancer treatments aiming improvement of QOL
- 2011-12-31
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- Study of Advanced life support for Ventricular fibrillation with Extracorporeal circulation in Japan
- Cardiopulmonary arrest on arrival(CPAOA)
- Teikyo University School of Medicine, Teikyo University Hospital
- 2008-10-01
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01